Mike Kerr

3.5k total citations
78 papers, 2.3k citations indexed

About

Mike Kerr is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Mike Kerr has authored 78 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Psychiatry and Mental health, 29 papers in Pediatrics, Perinatology and Child Health and 26 papers in Genetics. Recurrent topics in Mike Kerr's work include Epilepsy research and treatment (38 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Genetics and Neurodevelopmental Disorders (21 papers). Mike Kerr is often cited by papers focused on Epilepsy research and treatment (38 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Genetics and Neurodevelopmental Disorders (21 papers). Mike Kerr collaborates with scholars based in United Kingdom, United States and Ireland. Mike Kerr's co-authors include Anita Thapar, Janine M. Beavis, David Felce, Seth A. Mensah, Christine Linehan, Patricia Noonan Walsh, Kousuke Kanemoto, William Fraser, Marco Mula and W. Curt LaFrance and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of Clinical Epidemiology.

In The Last Decade

Mike Kerr

76 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Kerr United Kingdom 27 1.4k 845 463 443 400 78 2.3k
Rohit Shankar United Kingdom 26 1.4k 1.0× 723 0.9× 442 1.0× 309 0.7× 470 1.2× 230 2.4k
Holger J. Sørensen Denmark 28 1.0k 0.7× 300 0.4× 231 0.5× 619 1.4× 213 0.5× 77 2.2k
Jane Williams United States 25 838 0.6× 677 0.8× 132 0.3× 392 0.9× 139 0.3× 66 1.8k
Martin E. Rickert United States 26 431 0.3× 763 0.9× 833 1.8× 502 1.1× 97 0.2× 75 2.3k
Lauren M. Ellman United States 30 889 0.6× 419 0.5× 624 1.3× 984 2.2× 85 0.2× 119 3.1k
Colin Reilly United Kingdom 25 1.5k 1.1× 971 1.1× 96 0.2× 442 1.0× 348 0.9× 91 2.0k
Stephen J. Ferrando United States 29 659 0.5× 169 0.2× 285 0.6× 854 1.9× 84 0.2× 94 3.0k
Helen Heussler Australia 23 369 0.3× 307 0.4× 152 0.3× 283 0.6× 400 1.0× 103 1.7k
Susanne Wicks Sweden 24 529 0.4× 270 0.3× 274 0.6× 498 1.1× 122 0.3× 39 1.6k
David Branford United Kingdom 20 463 0.3× 157 0.2× 434 0.9× 292 0.7× 252 0.6× 38 1.2k

Countries citing papers authored by Mike Kerr

Since Specialization
Citations

This map shows the geographic impact of Mike Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Kerr more than expected).

Fields of papers citing papers by Mike Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Kerr. The network helps show where Mike Kerr may publish in the future.

Co-authorship network of co-authors of Mike Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Kerr. A scholar is included among the top collaborators of Mike Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Kerr. Mike Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hollinghurst, Joe, Ashley Akbari, Alan Watkins, et al.. (2023). COVID-19 vaccination uptake in people with epilepsy in wales. Seizure. 108. 49–52. 3 indexed citations
4.
Ashby, Samantha, et al.. (2023). “Untold Distress” – How did the COVID-19 pandemic affect those who had previously experienced an epilepsy-related bereavement?. Epilepsy & Behavior. 139. 109071–109071. 1 indexed citations
5.
Hurt, Lisa, et al.. (2020). Use of telehealth for facilitating the diagnostic assessment of Autism Spectrum Disorder (ASD): A scoping review. PLoS ONE. 15(7). e0236415–e0236415. 65 indexed citations
6.
Rapport, Frances, Patti Shih, Armin Nikpour, et al.. (2019). Determinants of health and wellbeing in refractory epilepsy and surgery: The Patient Reported, ImpleMentation sciEnce (PRIME) model. Epilepsy & Behavior. 92. 79–89. 8 indexed citations
7.
Kerr, Mike, Lance Watkins, Heather Angus‐Leppan, et al.. (2018). The provision of care to adults with an intellectual disability in the UK. A Special report from the intellectual disability UK chapter ILAE. Seizure. 56. 41–46. 17 indexed citations
8.
Copeland, Lauren, Andrea Meek, Mike Kerr, et al.. (2017). Measurement of side effects of anti-epileptic drugs (AEDs) in adults with intellectual disability: A systematic review. Seizure. 51. 61–73. 10 indexed citations
9.
Thomas, Rhys H., et al.. (2013). The importance of the experiences of initial diagnosis and treatment failure when switching antiepileptic drugs. Epilepsy & Behavior. 29(3). 492–496. 6 indexed citations
10.
Trimble, Michael, Albert P. Aldenkamp, Dale C. Hesdorffer, et al.. (2011). The Neuropsychiatry of Epilepsy. Cambridge University Press eBooks. 29 indexed citations
11.
Clarke, Angus, et al.. (2011). Epilepsy in Rett syndrome: Association between phenotype and genotype, and implications for practice. Seizure. 20(8). 646–649. 40 indexed citations
12.
Thomas, Rhys H., et al.. (2010). Implications for families of advances in understanding the genetic basis of epilepsy. Seizure. 19(10). 675–679. 7 indexed citations
13.
Veenstra, Marja Y., Patricia Noonan Walsh, H. M. J. van Schrojenstein Lantman‐de Valk, et al.. (2010). Sampling and ethical issues in a multicenter study on health of people with intellectual disabilities. Journal of Clinical Epidemiology. 63(10). 1091–1100. 18 indexed citations
14.
Gallop, Katy, D Wild, L Verdian, et al.. (2009). Lennox-Gastaut Syndrome (LGS): Development of conceptual models of health-related quality of life (HRQL) for caregivers and children. Seizure. 19(1). 23–30. 47 indexed citations
15.
Elst, Ludger Tebartz van, Gus A. Baker, & Mike Kerr. (2009). The psychosocial impact of epilepsy in older people. Epilepsy & Behavior. 15(2). S17–S19. 5 indexed citations
16.
Kerr, Mike, Mark Scheepers, Maria Arvio, et al.. (2009). Consensus guidelines into the management of epilepsy in adults with an intellectual disability. Journal of Intellectual Disability Research. 53(8). 687–694. 59 indexed citations
18.
Walsh, Patricia Noonan, Mike Kerr, & H. M. J. van Schrojenstein Lantman‐de Valk. (2003). Health indicators for people with intellectual disabilities: a European perspective. European Journal of Public Health. 13(suppl 3). 47–50. 44 indexed citations
19.
Kerr, Mike & Clare Bowley. (2001). Multidisciplinary and Multiagency Contributions to Care for Those with Learning Disability Who Have Epilepsy. Epilepsia. 42(s1). 55–56. 12 indexed citations
20.
Espie, Colin A., Mike Kerr, Audrey Z. Paul, et al.. (1997). Learning disability and epilepsy. 2, A review of available outcome measures and position statement on development priorities. Seizure. 6(5). 337–350. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026